The Michael J. Fox Foundation for Parkinson’s Research and the Center for the Advancement of Science in Space yesterday inked a collaboration to send a protein linked to Parkinson’s disease to the International Space Station.
The researchers plan to evaluate the protein’s growth under microgravity conditions, which could foster larger, more regular LRRK2 protein crystals to grow and give insight into the protein’s structure. A better understanding of LRRK2’s structure could help design therapies optimized against the protein.
Get the full story at our sister site, Drug Delivery Business News.
The post Parkinson’s protein to take a trip into space appeared first on MassDevice.